Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,311 | -10,467 | -11,636 | 542 | -2,147 |
| Depreciation Amortization | 516 | 380 | 581 | 256 | 358 |
| Other Working Capital | 1,175 | 177 | 655 | 401 | -2,164 |
| Other Operating Activity | 0 | 0 | 0 | 50 | -20 |
| Operating Cash Flow | $-14,621 | $-9,910 | $-10,400 | $1,249 | $-3,974 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,211 | -2,010 | -1,524 | -7,834 | 4,197 |
| PPE Investments | -426 | -687 | -905 | -182 | -5 |
| Investing Cash Flow | $-2,637 | $-2,696 | $-2,429 | $-8,016 | $4,192 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 125 | 10,000 | 20,000 |
| Debt Repayment | -151 | -138 | -82 | -10,000 | -20,000 |
| Common Stock Issued | 16,117 | 14,074 | 12,709 | 5,175 | 585 |
| Other Financing Activity | 0 | 0 | 0 | 350 | 0 |
| Financing Cash Flow | $15,966 | $13,937 | $12,751 | $5,525 | $585 |
| Beginning Cash Position | 1,709 | 378 | 455 | 1,697 | 894 |
| End Cash Position | 417 | 1,709 | 378 | 455 | 1,697 |
| Net Cash Flow | $-1,292 | $1,331 | $-77 | $-1,242 | $802 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,621 | -9,910 | -10,400 | 1,249 | -3,974 |
| Capital Expenditure | -426 | -687 | -905 | -182 | -39 |
| Free Cash Flow | -15,047 | -10,596 | -11,305 | 1,067 | -4,013 |